TABLE 4.
Control n=126 | CD n=125 | CD patients
|
||||
---|---|---|---|---|---|---|
Females n=87 | Males n=38 | Children n=90 | Adults n=35 | |||
ALT (P50) | 21 | 37* | 36 | 37 | 40 | 31** |
(P5–95) | 13–58 | 20–74 | 18–90 | 23–76 | 21–73 | 13–133 |
AST (P50) | 19 | 29* | 29 | 29 | 26 | 36* |
(P5–95) | 10–64 | 14–74 | 14–74 | 15–83 | 13–70 | 16–115 |
Ferritin (P50) | 33 | 20* | 21 | 16 | 20 | <15* |
(P5–95) | <15–224 | <15–54 | <15–53 | <15–145 | <15–66 | <15–34 |
*P<0.01;
**P=0.07